Summary
Eli Lilly and Company (LLY) filed an 8-K on April 24, 2018, primarily to announce its first quarter 2018 financial results. The filing incorporates by reference a press release dated April 24, 2018, which details the company's operating results for the period ending March 31, 2018. Investors should refer to Exhibit 99.1 for the specific financial performance data, including unaudited operating results. While this 8-K is procedural in nature, it serves as the official notification to the market of Lilly's quarterly performance. The press release attached provides the detailed financial figures and may also contain forward-looking statements and management commentary on the company's performance and outlook. Investors are encouraged to review the full press release for a comprehensive understanding of Lilly's financial condition and operational highlights during the first quarter of 2018.
Key Highlights
- 1The 8-K filing on April 24, 2018, serves as notification of Eli Lilly & Co.'s (LLY) first quarter 2018 financial results.
- 2Exhibit 99.1, a press release dated April 24, 2018, contains the unaudited operating results for the period ending March 31, 2018.
- 3The filing is procedural, with the detailed financial information being furnished and not deemed 'filed' under certain SEC provisions.
- 4Investors need to review Exhibit 99.1 for specific first-quarter financial performance data.
- 5The press release may include management's commentary on performance and future outlook.